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Introduction
The term herpes simplex, by common usage, refers to a
recurrent illness usually characterized by a single blister,
or small group of blisters, about the mouth. To most people
this condition is familiar as the annoying, yet generally
benign "cold sore" or "fever blister" which refuses to res-
pond to treatment in a satisfactory manner, but regresses and
disappears in due course* Fortunately, this most frequent
manifestation of infection with the virus of herpes simplex
is relatively trivial. Other less common clinical pictures
range from painful lesions involving the mouth and pharynx,
to diffuse often severe eruptions of the skin, and occasion-
ally fatal infections (73, 78) • The virus affects the geni-
talia, and not uncommonly the cornea, and may involve the
central nervous system where it gives rise to less well de-
fined symptoms. Cases have also been reported of involvement
of the internal organs (56)# Burnet (17) has stated that ex-
cept for the common cold, herpes simplex is the most frequent
viral disease of man.
Although recovery from many viral diseases results in
an immunity which lasts for years, it is well known that in
herpes simplex there is no protection from subsequent attacks.
Patients frequently undergo ten or more repeated episodes
yearly with little reduction in severity until late in life.
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To explain reinfections, which seem to occur without re-inocu-
lation, it has been suggested that the source of the virus is
intrinsic, with the virus generally persisting once the host
has become infected (17) • In this way, clinical symptoms can
recur following any of a large number of "trigger" stimuli,
such as overexposure to sunlight, emotional upsets, and the
like. The manner of activation of the latent virus is unknown,
but may be considered to depend upon certain " 'predisposing
factors 1 which tend to lower the resistance of the » • • • •
tissues" (41)
.
Of the current forms of treatment, none have been en-
tirely satisfactory* For the more severe herpes simplex In-
fections, therapy is entirely symptomatic (41, 73). With the
more common recurrent type of lesion, treatment is usually
not required, nor is it generally effective when applied. Al-
though there have been several reports to the contrary, the
broad-spectrum antibiotics appear to have little value except
in limiting secondary infection (27). Some consider the sole
effective treatment of the recurrent herpetic lesion to be the
use of repeated smallpox vaccinations.
The use of this method in the suppression of recurrent
herpetic infection appears to have developed as a result of
the widespread adoption of vaccination for the prevention of
smallpox. Jenner in 1804 devoted a lengthy report to a con-
sideration of cases in which recurrent attacks disappeared or
—ill x^Xcf'i
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lessened in frequency following vaccination, and he expressed
his belief that this was due to the "constitutional reaction*1
produced by the vaccine (63). In addition, he noted that
vaccination with calf lymph might fail to "take" in a subject
with herpetic vesicles, a point which Roxburgh (65), in 1927,
considered to be quite interesting inasmuch as such cases were
not heard of in more recent years. Certain other clinical
records have revealed that few people (2 cases out of 3000)
suffer from concomitant herpes and smallpox (65).
The methods which have developed from these and other
observations for treating herpes simplex infections by smallpox
vaccination are all very much alike. Briefly, they call for
the patient to submit to a course of from 2 to 12 vaccinations
at weekly or bimonthly intervals, with the punctures performed
either directly over the affected area, when cosmetic effects
are not important, or on some other part of the body. Preund
(32) treated 7 cases of genital and extragenital herpes in
this way and reported freedom from recurrences for at least
seven months. Mlnami and Ohmichl (57) followed 10 cases of
herpes genitalis over a period of two years witii 7 out of 10
patients showing Improvement or cure. In 1934 Wise and Sulz-
berger (87) reported satisfactory results with repeated vao-
clnations in some, but by no means all, of their patients.
Similarly, Foster and Abshier (29) observed only 5 recurrences
..0
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of symptoms in 35 patients at the end of two years • Cases of
corneal herpes (24), ulcers of the mouth and tongue (42, 64,
89), and additional cases of cutaneous herpes (4, 40) have
been the more recent to appear among reports in which favorable
results were obtained.
To balance this rather enthusiastic picture, a number of
clinical reports have dealt with the apparent failure of small-
pox vaccine to protect (11, 49). Although these may represent
only a small fraction of the actual failures encountered in
general practice, they are represented in a larger sense by
the general attitude of some reviewers that vaccination is of
little value (9, 13, 46).
Blank (10) and others (16, 25, 50) have questioned the
identity of the infecting virus in certain cases attributed to
herpes simplex. They found that many of the cases of recurrent
stomatitis (aphthous ulcers) are not due to herpes simplex as
formerly believed, but that the cause of this condition in
most patients is obscure. In this respect, Ronchese (64) has
presented the case of a woman suffering from this condition
who showed decided improvement after three inoculations against
smallpox. This interesting response of a presumably non-her-
petic condition to smallpox vaccine has not been commented
upon by other observers. Grace (42) has presented a similar
case.
Blank and Brody (11) in discussing the apparent clinical
successes obtainable in treating recurrent herpes with smallpox

vaccination suggest that this may he in reality nothing more
than "suggestive therapy" • They were able to bring rapid re-
lief to 10 individuals by alleviating, through psychiatric
treatment, feelings of shame or guilt associated with the
symptoms* Blank (9) feels that in view of the absence of any
detailed clinical studies using a control, such as heat-inac-
tivated calf lymph on alternate cases, a proper evaluation of
vacclnial treatment cannot be made* Baldrldge and Sternberg
(5) add that the frequency of spontaneous remission of herpetic
lesions makes it unwise to venture any opinion favoring the
use of smallpox vaccine for the suppression of recurrent herpes
simplex infection*
It has been claimed that the effect of successive small-
pox vaccinations is to raise the herpes simplex antibody titer
by injection of a related virus (29) • Unfortunately, as Bald-
ridge and Sternberg (5) point out, it has been repeatedly shown
that individuals subject to herpes generally possess high anti-
body levels at all times* Nevertheless, some success has been
obtained in alleviating recurrent herpes through the use of
formolinized herpes virus (13, 31) and the autogenous inocula-
tion of herpetic vesicle fluid (51, 72).
In an attempt to explain the beneficial effects of small-
pox vaccination on recurrent herpes simplex infections, early
investigators turned from clinical trials to an examination of
possible immunologic relationships. Gildemeister and Herzberg

in 1925 and 1927 produced evidence that when the rabbit cornea
and guinea pig foot pad were immunized against herpes virus,
these areas also showed a partial immunity to variola virus*
A definite viral relationship was therefore claimed, which was
further supported by In vitro neutralization experiments based
on the inactivation of variola virus by herpes antiserum pre-
pared in the rabbit* Similarly, these workers found that ani-
mals immunized with variola virus developed only mild reactions
upon injection of herpes. These observations were confirmed
and extended by St* Zurukzoglu (66), whose paper appeared early
in 1927 along with the second paper of Glldemeister and Herzberg*
Working with vaccinia virus in the place of variola, he indi-
eated that a distinct partial immunity did exist between the
two viruses* However, vaccinia immunized guinea pigs were less
immune to herpes virus than herpes immunized guinea pigs were
to vaccinia virus. Preund and Eeymann (33) have provided con-
firmation of these findings*
Since the appearance of the above papers between 1925
and 1927, no new or confirmatory evidence has been advanced*
Several teams have repeated the cross immunity and serum neu-
tralization tests, but with completely negative results* The
work of Bedson and Bland (8) is particularly revealing in that
they have taken into account the blocking effect that a prior
inflammatory skin reaction may have on a virus applied to the
same area. First, they inoculated herpes or vaccinia virus
t ( 36)
on the shaved skin of guinea pigs, and after allowing 4 to 6
weeks for recovery, tested the animals for immunity with the
same virus. If the results of this test were satisfactory,
the second virus was titrated on the skin, being careful that
the highest test dilutions were placed over the area of the
strongest "take" given by the immunizing virus. Thus, the
experiments have been weighted in favor of the findings of
Gildemeister and Eerzberg* In all cases, nevertheless, the
lesions resulting from the challenge virus differed little from
the controls*
Serum neutralization tests were also repeated* Rabbit
antiserum diluted 1:2 was mixed with varying dilutions of homo-
logous or heterologous virus, allowed to interact for one hour
at room temperature, and then inoculated into guinea pigs by
scarification* Again there was no cross protection© The au-
thors conclude, consequently, that the viruses of herpes febra-
lis (herpes simplex) and vaccinia are unrelated* Commenting on
the original observations of Gildemeister and Eerzberg, Bedson
and Bland write:
"Had the work of Gildemeister and Eerzberg consisted
only of cross-protection experiments in the animal,
frequently entailing superimposition of inoculations,
one would have been less ready to pay heed to their
conclusions* But they reported in addition neutra-
lization experiments with specific sera which bore
out their in vivo findings*"
They note that this has not been the experience of others*
The techniques of Bedson and Bland have been modified by

8.
several groups with essentially the same results • Perdrau (63),
and later Thompson and Buchbinder (85), used rabbits known to
be immune to either herpes simplex or vaccinia by intracerebral
challenge* Introduction of the heterologous virus by dermal
or intracerebral routes failes to reveal any immunity whatso-
ever* Olitsky and Long (61) reported similar findings in
guinea pigs, and Kanazawa (48), in mice* In the latter case
both fresh and phenolized herpes virus and vaccinia virus were
used for immunization* As before, no cross immunity was de-
tected*
To complete the immunologic investigations of a possible
relationship between smallpox vaccination and herpetic infec-
tion, Smith (79) attempted specific and cross antibody absorp-
tions with the viruses of vaccinia and herpes* Only the speci-
fic reaction could be demonstrated* Lastly, Gildemeister and
Ahlfeld (37) using passive protection tests, showed that a sub-
cutaneous injection of 0.5 ml smallpox vaccine did not protect
mice against simultaneous cutaneous injection of herpes virus*
The use of complement fixation tests in this problem has not
appeared in the literature.
The preceding investigations have constituted a type
carried out up to 1938. More recently, a number of different
experiments have been devised which point to more fundamental
differences in the behavior of the two viruses; that is, in
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their intracellular position. These experiments, first of all,
may be considered as logically following the work of Levaditi
and Reinie"(54) and Levaditi (53) who were able to pass both
vaccinia and herpes at the same time intracerebrally in rabbits.
They have stated that the two viruses "can exist together, in-
definitely and symbiotically in the brain and cord of rabbits • •
• • • • « This has been established during 18 consecutive pas-
sages Anderson (3), a year later, following the original
suggestion of Syverton and Berry (83, 84), showed that herpes
simplex and vaccinial inclusions could be found in the same
cells of the chick chorioallantoic membrane. These doubly in-
fected cells were located with difficulty and not with any de-
gree of regularity, as was emphasized by Syverton (82) who
could find only one such cell after making numerous serial sec-
tions of the virus-inoculated conjunctival sacs of three rab-
bits. Typically, the irregular intranuclear inclusion bodies
characteristic of cells infected with herpes simplex could be
found along with the larger, more spherical lntracytoplasmic
inclusions characteristic of vaccinia. The possibilities of a
mistaken interpretation caused by one cell overlying another
were fully appreciated, and care was taken to minimize the
likelihood of this error. Gaylord et al. (35), Bang (6) and
others, have shown the vaccinial inclusions to be aggregates
of elementary bodies.
Although the inclusions of herpes simplex are nuclear
in location, evidence adduced by centrifugation studies on the
o .'- e a
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separation of structural units of cells has indioated that the
virus is more richly associated with the cytoplasm (30) • Fran-
cis and Kurtz (30) feel that there is no selective binding of
virus to nuclei or to nuclear nucleoprotein, and with Bang (6),
believe that the inclusions are not herpes virus. This view
is also taken by Ackermann and Kurtz (1) who employed cell
fractionation technic in their work*
Despite the above statements, however, there is con-
vincing evidence that during the early stages of development
the herpes inclusions do represent an aggregation of actual
viral material. As Crouse and her coworkers (23) have pointed
out (confirmed by Wollman and Baker (88), it is possible to
demonstrate a positive Peulgen reaction on these inclusions,
showing that they contain desoxyribose nucleotides* Further-
more, Scott _et al* (74), in a recent paper, have shown by
histological methods that during the first 10 hours of infec-
tion of rabbit corneal cells, a series of changes occurs in
the cell nucleus leading to the development of a rare, shrunken,
type A inclusion body* The more usual "fully formed" inclusion
which appears at about 12 hours, is apparently only a stage in
viral development, although probably the final one* Both Fran-
eis and Kurtz (30) and Ackermann and Kurtz (1) are criticized
for not taking this sequence into account, and for examining
the inclusion body for virus at 48 hours when presumably no
virus was left. The inclusion can therefore be regarded as a

Feulgen negative skeleton just prior to and after the release
of virus from the cell, whereas early in the growth cycle it
is Eeulgen positive* Confirmation of these observations is
provided first by Gray and Scott (43), who have indicated by
means of cell fractionation that virus is associated with the
nucleus at a definite stage in the growth cycle; secondly,
Morgan et al* (60), with the electron microscope, have indi-
cated the presence of elementary bodies in the nuclear inclusions*
Briefly summarized* the development of herpes simplex
inclusions, and virus, in the nucleus, and vacclnial inclusions,
and virus, in the eytoplasm, serves to emphasize a major dif-
ference between the two viruses, which may be added to the
intnunological differences already mentioned*
Growth curves have been determined for a large number
of viruses in animals, tissue culture, and developing chick
embryos* Practical applications of such growth curves have
been limited, however, but have yielded valuable information
(55) © For example, the effect of a variety of chemicals on
the growth of poliomyelitis virus in tissue culture has been
described by Brown (15), and Briody and Stannard (14) have
tested the effects of the acridine compound, proflavine, on
the growth of mumps, influenzal, Newcastle disease and vac-
clnial viruses in the chick embryo. Burnet and Lush (18) and
Shaffer and Enders (70) have noted the effects of immune serum
on herpes simplex virus multiplication in the chick embryo,
( si
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and Cheever and Daikos (22) have extended this to Include the
effect of gamma globulin*
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Presentation of the Problem
In examining the relationship of herpes simplex and
vaccinial viruses, the likely assumption is made that the
possible suppressing effect of vaccinia is a result of viral
interference. Indirectly, this assumption has been subjected
to extensive study in the past, through experiments dealing
with five of the six hypotheses for interference as presented
by Henle (45) • However, one basic question remains unanswered -
namely, can vaccinia virus or its products actively destroy
herpes virus? Rather than design an experiment to answer
this question, it was felt to be more logical to examine as
many of the factors involved in interference at one time as
possible* To accomplish this purpose, the technic of the
virus growth curve was chosen, since it offers a highly sen-
sitive procedure that is very likely to permit the detection
of subtle changes*
i
.v :
Materials and Methods
Viruses , The herpes simplex virus employed throughout
this study was a mouse adapted HF strain * with a uniformly
high neurotropic infectivity. It was originally isolated by
Flexner and Amos (42) from the fresh lip vesicle of a subject
very prone to attacks of febrile herpes, and has since been
maintained for more than 25 years in experimental animals.
The virus as received was reconstituted from the lyophilized
state with 0,85 per cent NaCl and inoculated in 0.03 ml quan-
tities into the brains of Harvard strain Swiss albino mice.
These animals developed signs of an encephalitis and died
within from two to three days The brains were as optically
removed, pooled, and from them an emulsion prepared that was
used for further mouse passages. In the present series of
experiments the 19th to 33rd mouse passages were used. The
infectivity titer of these passages, as measured by intracere
7 9 8 4bral test, was between 10 * and 10 * MPLD (See page 17),
The vaeclnial viruses employed were of two types: one
for animal immunization, was the standard vaccine preparation
of the Massachusetts Department of Public Health, Division of
Biologic Laboratories, Its history and origin are uncertain,
but it appears to be a mixture of two strains of vaeclnial
* Obtained from Dr, Howard B. Slavin as the 337th passage In
mouse brain in his laboratory. It was lyophilized on June
20, 1951, The designation HF used throughout this paper
refers to this strain of herpes simplex virus.
)0
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virus obtained respectively in 1920 and 1947 from the New
York City Board of Health. The second virus, used for chal-
lenge, was the Levaditi (L) strain** It was lethal for 3-
to 5-week old mice by the intracerebral route of inoculation,
killing with an MPLD titer of 104 ° 3 to 10
5 ° 3
within five to
eight days. Experiments were performed with brain suspensions
representing the 3rd mouse passage.
Preservation of viruses . In view of the pronounced
instability of herpes simplex virus in physiological saline
solution and the difficulty of maintaining material of a con-
stant potency, no effort was made to preserve a fluid brain
pool of the HF strain. Rather, the samples of virus employed
in individual experiments were derived directly from fresh
brain passages. Seed virus for these passages consisted of
brains which had been stored in paraffin (Parafilm) sealed
Petri dishes at - 40 C.
The L strain of vaccinial virus was stored at - 25 C
and retained uniform activity as a 10 per cent brain suspension
in 0.01 M phosphate buffered saline solution at pH 7.2. Sam-
ples of virus were dispensed in 2 ml quantities into screw cap
tubes and frozen.
Assays for virus . The EF strain was assayed in the fol-
lowing manner. Suspensions of infected mouse brain were pre-
pared by grinding fresh tissue in a chilled mortar with sterile
* Received from Dr. E. A. Briody as a 1:2 dilution of (?) per
cent mouse brain in 50 per cent glycerol.
•
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alundum and a small quantity of gelatin saline solution** Suf-
ficient diluent was added to give either a 10 per cent or 3L6
per cent brain suspension by weight (the latter concentration
to permit the detection of virus in the low concentration of
10
1 * 5
MPIlJ, and the material centrifuged in the cold (2-4 C)
at 2000 rpm for 30 minutes (950 RCP (g) with an International
No* 249 head) or 3000 rpm (2000 RCF (g))for from 45 to 60
minutes. When it was important to have the supernatant fluids
relatively cell free, as for example in the work dealing with
growth curves, the higher speed was always employed. The su-
pernatant fluids thus obtained which represented the virus
preparations, were tested for bacterial sterility. No notice-
able bacterial growth took place either here or in mice re-
ceiving this material and it was felt unnecessary to incorpo-
rate antibiotics into the inocula. The quantitative measure-
ments of virus were carried out in Harvard strain Swiss albino
mice approximately 3 weeks old. Groups of five animals were
inoculated intracerebrally, without ether anaesthesia, with
0.03 ml of serial 10-fold dilutions of virus. They were then
observed daily for ten days for the occurrence of death. Ani-
mals dying within 24 hours were considered as nonspecific
deaths and were excluded from the calculations.
Assays of vaccinial virus activity with the L strain
* Isotonic phosphate buffer solution (86) with 0.5 per cent
gelatin (Difco). This diluent is used throughout this work.

were carried out in essentially the same manner as described,
with the exception that the diluent did not contain gelatin.
Suspensions were centrifuged only at 2000 rpm for 30 minutes.
Analysis of data . Estimations of infectious titers
were made according to the method of maximum likelihood (97),
using the tables of Hoskins (47) and Prescott (6la). Results
are expressed as the most probable lethal dose of virus (MPLD
per ml of inoculum). These were calculated from the distribu-
tion of deaths in three groups of five mice, each of which
received successively higher serial dilutions of virus, usually
10-fold. This method offers several advantages over the cus-
tomary Reed and Muench (62) determination of the 50-per cent
end point when decimal dilutions are employed, most important
of which is avoidance of the error inherent in the "accumula-
tion method" of analysis. In addition, an approximate value
may be obtained in those instances in which fewer than half
the mice die in the lowest viral dilutions. For deaths among
a small group of animals, this may afford a more suitable ana-
lysis than is obtained with other methods.
The standard error of the log of the MPLD was calculated
by an amplification of the methods of Fisher (27a). Using 10-
fold serial dilutions, five mice per point, the standard error
with 95% confidence limits is o46. The error is less in those
cases when the first dilution is 1/2 log. The minimum differ-
ence to which significance has been ascribed in the present
experiments is ^ 1/2 log.
:::/:>0.
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Growth curves * Groups of mice 3 or 4 weeks old were
inoculated intracerebrally with HP virus in 10"^, 10" and
10"^ suspensions* Smaller groups of 5 or 6 mice were killed
with chloroform after various intervals following inoculation
and their brains pooled for titration. These were carried out
immediately without waiting for the remaining animals to he
sacrificedo
Technic of vaccinial immunization o Suckling mice, 3
days old, were vaccinated on the skin of the hack with vac-
cinial virus (Lot Nos* 310, 316, 319, 320 and 324)** An amount
of viral suspension estimated at 0.004 to 0*005 ml (on the
basis of 4 or 5 animal applications per tube) was applied to
the back of each animal, and through this material the back
was lightly scarified 20 to 25 times with the tip of a sharp
dissecting needle. This was sufficient to produce a deep red
flush, but not heavy enough to break through the skin* The
mortality rate with this procedure lay between 15 and 20 per
cent, the majority of deaths occurring within two weeks© In
certain instances, approximately 24 days after immunization,
and 4 days before the use of these mice in experiments, a
—2booster dose of 0.25 to 0,5 ml of a 10 suspension of vac-
cinial virus was administered intraabdominally* In one experi-
ment this dose was repeated one hour prior to their use© The
mice used as controls for those Immunized were derived from
litters born on the same day*
* Vaccination of younger animals (several hours old) gave a
slightly poorer degree of protection as indicated by sub-
sequent challenge*
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Results
Several attempts were made to find a simple and direct
means of estimating the concentration of HF virus in tissue
preparations. These included various agglutination technics
which had been successfully applied to the study of a variety
of viruses, but never clearly established as functioning in
systems involving herpes simplex.
Hemagglutination tests . According to the recent report
by Geller _et al. (36), five egg adapted strains of herpes sim-
plex virus failed to agglutinate the red cells of several dif-
ferent animal types when examined by direct and indirect tests
(See below). This is contrary to the earlier experience of
Moolten and his associates (59) who consistently found the
virus to cause autohemagglutination of patients' cells in vivo
and indirect hemagglutination of cells sensitized with herpes
simplex virus in vi tro . While these latter observations were
being made, experiments were underway by the author offering
additional evidence of the nonhemagglutinating nature of herpes
simplex virus. The exact procedures followed are outlined here.
Human Group and fowl red blood cells were examined at
room temperature and at 37 C for agglutination in the presence
of serial twofold dilutions of a potent HP virus suspension.
The red cell concentrations were varied between 0.25 and 2.0
per cent (final concentration) and the pH maintained between
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7 1 and 7,2, Under these conditions no agglutination occurred,
either as gross clumping of the cells or as a Salk (67) pat-
tern* Tests were performed on a lucite plate (68) as well as
in standard Wassermann tubes
«
The indirect test was conducted by exposing red blood
cells to concentrated EF virus for 1$ hours, washing the cells
three times, and then adding them to serial dilutions of rabbit
EF immune serum. There was no agglutination, either at room
temperature or at 37 C,
In a third series of experiments, human Group cells
were treated with tannic acid according to the method of Boyden
(12). These cells were then used in repeating the preceding
indirect agglutination test. The results, as before, were
entirely negative.
Liver cell agglutination tests , A further series of
experiments was carried out, employing a preparation of cell
nuclei in the place of erythrocytes. Fresh rabbit liver was
prepared by the salt extraction method of Mirsky and Pollister
(58) so as to yield a concentration of nuclei estimated by
them to comprise more than half of the cell mass. Exposure of
this material as a 0,5 per cent suspension to an equal quanti-
ty of serially diluted virus resulted in no noticeable reaction.
The indirect agglutination test was not run with liver nuclei.
Developmental Pattern in the Mouse Brain
Growth curves for the HF strain of herpes simplex virus
in the brain of the mouse have been reported by Burnet and
£•
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Lush (19) and Cheever and Daikos (22). However, their data
are incomplete and do not lend themselves to a oritical ana-
lysis or to the purpose of this paper. The following work
was carried out to establish a more precise pattern of virus
development*
The effect of time and speed of c entrifligation on the
pattern of virus growth * Recovery of significant quantities
of virus during the latent phase of growth in mice has been re-
ported for equine encephalomyelitis virus (71), Newcastle dis-
ease and influenza viruses (21), and the Lansing strain of
poliomyelitis virus (2). The factors responsible for this re-
covery have not been definitely established. It was therefore
desirable to examine closely the early phase of the growth
cycle before determining the complete pattern of HF multiplica-
tion*
Accordingly, a series of experiments was conducted with
the premise that certain characteristics of the inoculum are
responsible for the failure of virus to disappear during this
phase of growth* A 10 per cent virus suspension was centrifuged
at 2000 rpm for 30 minutes* The slightly turbid supernatant
fluid was separated, a sample set aside (Supernate I), and the
remaining fluid recentrifuged at 3000 rpm for from 30 to 60
minutes* After removing a small sample of this supernate by
pipette (Supernate II), the remainder of the fluid was decanted
and discarded, and the sediment redispersed without further
treatment and made up to the original volume with gelatin saline
JO
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solution (Sediment). Thus, Supernate I represents the usual
inoculum which has been separated into a supernate (Supernate
II) and sediment (Sediment) • The growth curves obtained fol-
lowing the intracerebral inoculation of each of these prepara-
tions into mice are given in Figure 1 and Table I*
It is evident from an inspection of Figure 1 that after
inoculating the animals with Sediment, the concentration of
recoverable virus decreases at a much slower rate than in the
case of either of the supernates. At the end of 3j hours the
level of recoverable virus is as great as in the case of Super-
nate I, while that resulting from inoculation with Supernate
II has decreased almost to zero* From this we see that the
Sediment contains considerable virus present in such a state,
that after inoculation it is recoverable during that portion
of the latent period which shows up as the lowest point on the
growth curve. It may very well be that the failure to remove
this sediment from the usual growth curve inoculum* is to some
unknown extent responsible for the recovery of virus during
the latent period of the growth cycle*
Further, the curve obtained with Supernate II (Figure 1)
shows the presence of a consistently lower titer than that ob-
tained with Supernate I, and a somewhat quicker loss of re-
coverable virus at the start of the cycle* This is more clearly
shown in Figure 2, where Supernate I is represented by the upper
* It has been customary in virus work to clarify inocula by low
speed centrifugation (2000 rpm for about 30 minutes)*
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curve and Supernate II by the lower • Since the Inocula which
were used to obtain the two curves differ only by the removal
of cellular debris, one would expect that the curve obtained
by inoculation with Supernate II would be lower*
The differences observed by varying the speed of centri-
fugation are tabulated in Table II, and seen to advantage in
Figure 2. The two curves illustrated differ not only in that
the inocula used were centrifuged at different speeds (2000 and
3000 rpm), but also in that the brain pools used to determine
the points were also centrifuged at the same speeds used to
prepare the respective inocula. As mentioned before, the more
highly clarified inoculum yields a curve showing rapid loss of
recoverable virus; about 99 per cent within one hour. The
other curve, obtained with an inoculum containing sediment,
shows only a 50 per cent loss in the same time. From one to
four hours after inoculation, however, both curves show approxi-
mately the same rates of loss of recoverable virus and from
four hours on, the same rates of gain. Consequently, the dif-
ferences in recoverable activity that appear one hour after in-
jecting virus remain constant throughout the growth period.
This difference averages about 1 log unit. An increase in the
speed of centrifugation, therefore, will depress all points on
r
the growth curve, causing a downward displacement.* Possibly,
*In this experiment, as well as in others, a separate pipette
was used in preparing each dilution. This avoids the possibility
of tissue particles adhering to the glass and carrying over into
higher dilutions. Such an error has been observed here, and
by others (55, 80), to result in abnormally high titers. Despite
this precaution, however, MPLD titers upwards of 10H»9 have
been obtained for 10-1 brain suspensions clarified at 2000 rpm
for 5 minutes.
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this may represent nothing more than the effect of a simple
decrease in the size of the inoculum, such as would result from
the removal of potentially infective cellular debris.
Growth curves and the effect of varying dosage * In a
series of six experiments, the growth curves were determined
for three different concentrations of HP virus. No more than
two of the three concentrations were run at one time, hut the
reproducibility of the curves within 0.5 log units for
nearly all points, permits a rough comparison of the three.
This has been done graphically in Figure 3 for 10"^, 10"3 and
c 7 8 fi 4.10"° suspensions, containing, respectively, 10 •
,
10o<* and
4.410 * MPLD per ml. Table III presents the crude data. The
curves presented are typical values of these experiments.
Examination of the data reveals a cycle of development
in the mouse brain conforming to the general picture of multi-
plication for a large number of animal (2, 21, 71) and bacterial
(55) viruses. During the first hour or two following inocula-
tion there is a rapid drop in recoverable virus. This is fol-
lowed by a variable latent period, dependent upon the concen-
tration of virus originally injected, during which time little
or no virus is detectable. A sharp rise between the 4th and
6th hours of the 10"1 curve, the 7th or 8th hour of the 10"3
curve, and the 11th hour of the 10" 5 curve suggests the advent
of the cell "burst"* and rapid increase in the number of virus
* The term "burst" is used here in referring to a sudden sharp
increase in virus concentration. The mechanism may be simi-
lar to that described for bacterial viruses (55).
~ r
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particles. The period of rapid multiplication may proceed in
a stepwise fashion, since, at the end of the latent period,
there appear to be two or three marked increases in activity
at intervals of about six hours. In some instances these steps
fall within the limits of normal variation 2 S.E. s ^£ 50%
of one log unit). The remaining steps, particularly with the
10 per cent inoculum, are constant enough to suggest that they
are real.
Prom an inspection of the curves, it is quite apparent
that they are very much alike. In addition to stepwise in-
creases they have similar initial slopes, thus suggesting a
uniform rate of virus multiplication independent of the size
of the inoculum. However, this similarity is lost as the virus
concentration approaches a maximum. Presumably the number of
cells not infected becomes a limiting factor in further incre-
mental growth. This is best illustrated by the data for the
10~5 curve of Figure 3. In this case, the rate of production
of virus decreases at about 30 hours.
The relation of survival time to dose « The time at
which the test animals can be expected to die is roughly pre-
dictable for a given inoculum if the time at which a maximal
titer is reached in the brain is known. Thus, with a 10 per
cent inoculum, this point is reached at about 15 hours, and
death generally follows at from 11 to 13 hours later. With
the more dilute inocula a maximal titer is reached at about 24
hours (10"3 dose) and 40 hours (10~5 dose) and death follows
^1
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about 20 hours after maximum titers are attained; that is,
at 2 days and 2§ days respectively. Concentrated inocula do
not seem to follow the pattern set by the diluted inocula, in
that they produce death very rapidly after reaching the maximal
titer. This perhaps reflects the overwhelming type of infec-
tion which is induced by the heavy inoculum.
The Relationship of Herpes Simplex and Vaccinia Viruses
Serological and immunological technics have been employ-
ed in the past in attempts to relate herpes simplex and vac-
cinia viruses. The results of these tests have been essential-
ly negative. Since clinical observations suggest that herpes
and vaccinia do possess some factor in common, it is perhaps
to be found on a possibly more subtle level than has yet been
considered. Changes in the reproducible pattern of HP virus
growth have been used as a sensitive means of detecting some
hypothetical altering factor in vaccinia virus.
The growth curve of herpes simplex virus in mice immu-
nized against vaccinia . Under clinical conditions the use of
vaccination to suppress recurrent herpes infection generally
results in a good immunity against vaccinia virus. The symptoms
of recurrent herpes frequently disappear as this immunity de-
velops, and they do not reappear - or do so only in a mild
fashion - for long periods of time after the disappearance of
circulating vaccinlal antibody. These conditions relating to
vaccinial immunity were readily simulated in mice, and their
effects on the growth curve of herpes simplex virus determined.
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Mice in the experimental group were vaccinated once at
the age of 3 days. A small group of these animals resisted an
intracerebral challenge of vaccinia L virus in excess of 104 °^
MPLD. At the age of 28 days, without having received any fur-
ther treatment, the vaccinated mice were inoculated intracere-
brally with 10 per cent virus suspension. Seven and one half
and 15 hours after inoculation, pooled brains of groups of mice
were titrated in normal animals© The data presented in Figure
4 and Table IV show that there is no alteration of HP virus
growth in vaccinated mice as compared with the normal.
It can be argued that large HF inocula may institute an
overwhelming infection, thereby obscuring possible relation-
ships between the two viruses. To avoid the implications of
this question, the above experiment was repeated using much
smaller inocula.
In the experiment recorded in Figure 5, vaccinated mice
received a total of two intraabdominal injections of vaccine
lymph given 4 days and 2 hours before injection of HF virus.
This simulates the condition of circulating vaccinia virus
found in man following vaccination, and introduces into these
experiments the possibility of interference between viruses.
Animals prepared in this manner showed the same resistance to
vaccinia L virus as those animals not receiving this injection
5 3(10 * MPLD per ml). From the data (Figure 5 and Table V),
there is a suggestion that vaccinial immunization has slowed

the multiplication of HP virus (10 MPLD inoculum). The
two curves expressing the rates of viral multiplication tend
to parallel each other© However, there is some suggestion
that the curves may be converging© Repetition of this experi-
ment with even smaller inocula of HF virus, and following the
growth curve from an earlier time period, did not confirm this
apparent difference. This is shown in Figure 6 with an HF
Inoculum of 103 ° 9 MPLD per ml* The crude data are given in
Table VI*
In performing this last experiment (Figure 6), it was
considered likely that some vaccinia virus would enter the
brain following intraabdominal injection and be introduced, in
turn, into normal mice when the brains were titrated* A con-
trol was therefore Included to detect the possible further
multiplication of this virus in normal mice* The control con-
sisted of vaccinated animals (one booster injection five days
before use) for a duplicate titration of pooled brains derived
from vaccinated mice* Normal mice were used as before in ti-
trating both normal and vaccinated groups* As indicated in
Figure 6, the carry-over of free vaccinia virus does not appear
to be a significant factor in this experiment*
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Discussion
The results presented In this paper contribute to a
clearer understanding of certain portions of the early phase
of viral growth* In addition, the complete pattern of herpes
virus in the mouse brain reveals a cycle of multiplication
which conforms to and enlarges upon similar curves defined on
the egg chorioallantoic membrane (75), and in tissue culture
of rabbit corneal cells (74) and fibroblasts (81) • This con-
firms the impression of Scott ^t al» (74) that the characteris-
tic growth of herpes virus is independent of any peculiarity
of the host tissues*
The Initial rapid loss of recoverable activity during
the first hour following the inoculation of HP virus, and the
second slower decline, have been observed in mice as well as
in tissue culture and chorioallantoic membrane* The first of
these decreases is generally considered to be due to the rapid
escape of up to 95 per cent of the Injected material via the cir-
culation (20)* The factors underlying the second decrease are
less clearly established,, Schlesinger (71), in describing a simi-
lar picture for Western equine encephalomyelitis virus, has cau-
tiously approached this second part of the growth curve, and has
suggested two alternatives: (a) that the recoverable virus repre-
sents the development of a temporary equilibrium between the
rate of disappearance of virus from the brain and an evolution
of new virus; and (b) that it is comparable to the "constant
z>czd': ^Xnae ©rid lo encltftoq nlBtebo lo anihrrBjteieftau »i©iboXo
oqiorf *o irsetf^Bq ©deXcnion eric* 4 noJt^f;jbA nl • ritfwo'ifc XirtiXv Tto
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periods 1* described for bacteriophage and influenza viruses.
A more precise interpretation of the factors controlling this
latent phase has been difficult where mice have been used as
the growth medium* However, data obtained by use of the de-
veloping chorioallantoic membrane of the chick embryo indi-
cate clearly that the concept of a constant period of virus
growth is to be preferred. In the following discussion, the
possible effects of circulating virus on the recoverable ac-
tivity in the latent period are not considered to be important.
On the basis of this concept, the information presented
in this paper, concerning the effect of removal of virus con-
taining cellular debris from the growth curve inoculum, may
be explained simply in terms of virus access and adsorption
to brain tissue. Thus, if an essentially cell-fSee inoculum
is introduced into the brain, the distribution of material is
principally to the intraventricular spaces (34, 69), and from
there to the circulation. The concentration of recoverable
virus is found to drop rapidly during this process until,
presumably, a point is reached where free virus has largely
disappeared from the brain. What remains, perhaps 1 per cent
(71) represents freshly adsorbed, infective material. The
second decline then seen is more gradual, and usually proceeds
to the point where virus is no longer recoverable. This phase
is most easily thought of as one of viral penetration and/or
the development of a state of non-infectivity (55). Now, if
the inoculum should contain a large amount of potentially
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infective cellular debris, It is most likely that escape of
this material from the brain will be limited by purely mecha-
nical factors* Tissue dissolution, however, will ordinarily
occur, so that virus is eventually liberated. Thus, virus can
be held at the principal site of adsorption over a relatively
long period of time* The net effect of this process is that
when brains injected with a sediment -containing fluid are ex-
amined during the latent, or constant, period, some virus is
always recoverable; the amount depending primarily on the
concentration of cellular debris in the inoculum* This ex-
planation assumes that cellular debris contains virus either
in an adsorbed or intracellular state* Eenle (44) has shown
that active influenza virus is found in allantoic membranes
collected and ground late in the latent period. Similar find-
ings have been reported for meningopneumonitis virus (77) and
the T series of bacteriophages (26)*
The indications are that cellular debris contains little
Infective material as compared to that found in the supernatant
fluids. This fact alone may explain the small concentration
of virus recovered directly after the inoculation of Sediment
(Figure 2) into mice, and during the first six hours of the
growth cycle* However, the possibility should also be con-
sidered that cellular debris may be partly removed by centri-
fugation when the brain pools are processed for titration, thus
automatically reduoed the infective titer of the material*
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There are many factors present in the HP virus -mouse
brain system which obscure the presence of the expected step-
wise multiplication of virus* The principal one, as advanced
by Scott et alo (75), is the continued adsorption of virus
over a period of several hours, and its subsequent multiplica-
tion and liberation over a period of time. Although most of
the virus can be expected to adsorb within about 15 minutes
(75), those portions which do not adsorb rapidly obviously
tend to obscure the development of any sudden "bursts" of virus
activity* This, plus the presence of unreleased, active virus
within the cell, should render such "bursts" even more unlikely..
Nevertheless, if sufficient virus is released at the end of a
growth cycle, the "bursts" will be pronounced enough to observe.
Scott jet al. (75) have estimated the increase in virus on the
chorioallantoic membrane during the incremental period to be
about 10-fold every two hours. This agrees with the findings
recorded here in mice, and should provide a sufficient con-
centration of virus during a single cycle (100- to 1000-fold)
to make these "bursts" apparent.
It is to be expected that a stepwise growth of virus
would be most easily determined where all the susceptible cells
were infected at one time. This has been consistently noted
following inoculation with 10 per cent suspensions of virus.
The single "burst" of activity at about 10 hours (Figure 2)
lies just at the limits of normal variation (^ 2 S.E. - ^ 50$
of 1 log unit) and therefore may be of doubtful reliability©
(
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However, the steps observed following inoculation with smaller
quantities of virus have been analyzed and the majority of
these appear to be significant* It is to be emphasized, never-
theless, that curves have been obtained with small inocula
showing no evidences of stepwise increase. It is assumed that
these curves are the result of overlapping growth cycles of
virus.
A number of conditions have been established in mice
which simulate the clinical use of vaccination in the treatment
of herpes simplex. These have included (a) no immunity, (b)
vaccinial immunity with probable circulating antibody, but
little or no circulating virus, and (c) immunity and large
concentrations of circulating virus* Inasmuch as the question
of a herpes-vaccinia relationship entails the possibility of
viral interference, these conditions may be expected to ful-
fill most of the requirements for interference as set forth
by Henle (45). The failure of any observable alteration to
occur in the growth pattern of HF virus suggests more forceably
that herpes simplex virus and vaccinia virus are unrelated.
However, it is wise to approach this apparently logical con-
clusion with some caution, since the localized, intracellular,
and generally benign nature of herpes simplex virus in patients
cannot be duplicated in experimental animals. This implies
that perhaps the precarious balance between latent and activa-
ted herpes simplex virus in patients is the key to a possible
herpes-vaccinia relation, and that the effect of vaccinia virus,
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or its antibody, is directed at blocking the activation of
small quantities of herpes virus, rather than preventing the
establishment of a new infection in a previously unaffected
area. In addition to subtle factors of cellular immunity
which are not adequately understood, this hypothesis may then
involve a question of concentration of virus. In other words,
only small amounts of herpes virus may be required to re-
establish a local lesion in man, whereas much larger amounts
may be needed to initiate infection in mice by the intracere-
bral route of inoculation. In a like manner, much smaller
amounts of vaccinia virus would then be required to suppress
the former type of lesion than to suppress the latter* The
unknown factor of the penetrability of brain tissue by vaccinia
virus therefore becomes an important consideration in the ex-
periments just discussed*
A conflicting note in the above reasoning is provided
by two reports that vaccinia virus can activate latent herpetic
infections in rabbits (52, 66), Perdrau (63), among others,
was unable to confirm this* Sharlit (76) has cited a case
where handling of smallpox vaccine was followed by a recurrence
of herpes* Although there is considerable question as to the
value of these reports of herpes activation by vaccinia, they
point nevertheless to other mechanisms that may function to
suppress the recurrent lesions* Thus, it is possible that
vaccinia virus could function as a continuous, specific or
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non-specific, activator of herpes virus, thereby raising the
level of herpes antibody locally, and so preventing the de-
velopment of symptoms.
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Summary
lo Mouse-adapted strains of herpes simplex virus failed to
agglutinate red cells of two different animal types when
tested by direct and indirect methods. Agglutination did
not occur with tannic acid treated cells or with a preparation
of liver cell nuclei.
2. Growth curves were determined for three different concen-
trations of herpes simplex virus in the brain of the mouse.
The patterns obtained agree with curves defined in tissue
culture and on the chorioallantoic membrane© This confirms
the impression of Scott _et al© that the characteristic growth
of herpes simplex virus is independent of the cell type©
3. The presence of cellular debris in the viral inoculum
results in the recovery of significant quantities of virus
during the latent period of virus growth* Removal of this
debris by increasing the speed of centrifugation to 3000 rpm
for from 45 to 60 minutes minimizes this effect© The probable
mechanism is discussed©
4© The development of herpes virus in mice immunized against
vaccinia was not significantly different from that in normal
animals© The significance of this finding is discussed in
the light of present concepts of vaccinlal therapy of recur-
rent herpes infection©
.
r
00
o
•rf CA©WO
e •MHO
CD
h i 1^
CD -P
03 ttf
©
VI
o
S
1
> G
3 ST
5
^
05
O
•H
d r-t
o
CD
** fJrH
«S O Ih -H O
*J o
ca «h
fn O
CD «rt
-P -P
6 5
1
o
-3- en 00 vr\ #s cvl
• • • • • • • • • •N o o r\ h h o cn
Cm cm c* i CM C A
iH iH iH rH
N K M M K
09. VO O 0\0
-3- \o VOVC m CM
•
*
VT\ VT>* CVJ
VP> VP> VP) XP> vr> vr\ vr» \r\
iH *r\ >T\ O
XT* u> \r\ \r»
CM O H r>
vn
H
O C 1
mJm
V \ XL/ w>
l-tM M
• CDP 4* p
a CD
u
<D <D
I •CO CO CO

38.
1
5
eh
o
a>
CD
IS
5
rH
4
4»
-H
>
* a
0} tH
It
O
SB
aH
s
pq
©
+»
CO
2
o
o
43
o
•8
©
o
tU) o
CD O •
« H O
(h a> ^
> CD
•H ft
CD +»
C3 O
a> t*0 vr\
BS9
u 1
ESS 2,
1 °?v (u o
O MC^O -tH I
S O
•H rH
<S 3
H -H I
a > o
**h H
•H O
VA
4* O O
-H rH
rH r-Ufr
^ ca
<D O
*H -P
OB ^
3
1
o tf
cm
ca *A vr,
rH rH
H
VA
CMO
.va
VTV
.va
^*
VA
^*
o
(A
vr\
VA
,VA
CM
VA
O
o o
ON VO
va
va
va
o
.va
VA
.VA
VA
pH
.VA
VA
.VA
*A
o o
vO
VA
.VA
VA
VA
.VA
CA
.VA
VA
.VA
.VA
VA
vn
CM CO VA VA Cm
CM CM CA tv
CMo
rH
(AO
rH
CAO
rH
O
rH
O
rH
VOO
iH
H H N H H H
VA
CM
VO
rH
VO
VA
vO
VA
vO
VA
CM
CO
^A
VA
VA
VA
VA
CM
VA
VA
^A
CA
.VA
O
VA
VA
.VA
VA
.VA
O
^A
VA
.VA
^-
VA
^A
O
.VA
VA
^A
VA
CA
VA
CM
O rH H CM CA vr\ vO CM
vr
vr
vr
vr
vr
CM
vr
CM
vn
o
vr
rH
O
CA
U
o
<H
S
o
o
o •
Cvl 03
rH
-P ,0
3$ <C
•P
$5
•H O
U rH
43 rH
PI O
© <H
o
9
u *>
©
> 6
o
. u
CO «H
3|o 3
ft
c
55 ^
-P Ai
a ca
4? e
<p O
M § *»
0) ©H O h
rO H aj
c o
EH O CM
ft
CD ©
© s4
CJ »H jHDP h
CD >h
•H 4>
<H 03
o S tJ
a.
n • ©
o e A
•h 3 EH
a o •
O 03
09
•H 4»
© © Pi
o
*
B
1
II
I
]
J
I
1Oi O
& H °
a> © u
> ©
« "H P
U oj 6
•H tvO Vf\
Sh
o
\C CO CO CM t^- CO Is-VO CO VT\CO
• •••••••••4
C\J O O O OHM (^n^xr
U
©
o
.4
-p
©
rH
1
O
It
K O
rl H
E
x
rH
«H
O
o o
2
•HI
03
VA
O
rH
3
o
© «Hp
-P
aJ 3
o
o
© O
N O
•H d
CM CM (A-* vr\\0
o o o o o o
iH iH iH rH iH iH
M X K K M M# * *
* * #
o ono\o ca cav© so vo
iH iH
VA
VA
va
va
o
v^ vr
va vr
va vr
vava va vr
4 >A H O
vava va va
\A-4" CA O
VA tArH O
va\a ^Ava
VA JOi va VA VA
CAVA VAO
va VAVA va
rH CM-* CM
rjto 'tS'cM VA COO HN4vD NOnH H H H
V "3
rH VOg
CA -4 fA rH CO O CM vr
• ••••••<O O O CM CMCM^-^J-VO
CM CM CACA-* va
o o o o o o
• *KHHKHH
* *(nOvAVfivOvO CMrHvO
CA v© CA CM rH «s CA f>-
vr
vr
va vr
va O
\A va JT
va O
VA VA^
VA CM CA
va va va VA VA
^ VA CA iH O
VA va >A VA VA
va CM CM O O
va va va VA VA
VA VA -4 O O
VA^A
CA va
H« O CM VACO -*
C^- «N rH rH rH rH CM
C
rH
CM ^ VA vr. O VAC^-rH
• •••••••OOOOrHCMCACACACA
CM CM CA CA CAO O O O O
# •
* *O CAM3
X K H K K
O v£> CM O CAVO
CAvO \D -5 »n CO CN- CM
VA
JA
VA
va vA^ryvA
VA va CA VA
va_va VA VA VA VA
va CA CM O H CM
va VA VA VA va VA va
VA-* CM rH O O O
VA VA vA VA VA VA
va vA-3" rH O O
VA^A^A
va VA-3"
ON4-VOC0 ON-*vo
•VHHHHHNW WN
O
rH
K 9
cm 2
1I
I
I
I
I
|
I
• ••••••
jj- J- -3" \^vo vrv
O O O O O O O
rH H rH rH rH rH rH
M M X M H X K
vOvfi H^O r\N H
CM 3- rH CM f-1
>r> \r\ vr\ x/^ vr\ vr\
\r\ v\JA *A \r\ vr\ vr\
\^ rA^fr ^ r-l O O
vry \r\ \r> >r\ vr\
CM CM O OJ O
O O O
CO © CM ^00 CM CO
cm cnc^f^co-3-
8
s
u
©
-p
o
*»
©
OB
rH
O
O
ft
c5
u
rO
03
-P
1
3 B .
8
O M3 O
O «HHOP
•H -P rj
rH
© vr\ -h
EH
E n
o 3
• ?H C
© «H -H
rO
c3 o o
-P <H >
a
•H ft >»
.fl fVf-H
-p a
• O OHBO
o o a
c ^ n-H
rH «H
rQ -P
o3 fl (fl
Eh ©
s
d
IB Q O
903
<D «H O
01 U -H O
o d hP 03
CA fl .fl
09 -P
o ©
oj>
©
-dH
5 §fl*
o fl
a ©p -p ea
a] cd fl aS
fl 4> *H rQ
03 03 ©
rH «d ft
© © rH
© jfl XI
o
Pm *
p >
#
*
I
I
+>
s
I
14
O
XI
1
5
^ «H Hi© O
a c^
u wo
a> o <h H O
© > ©
•H P
a +>
p (J 6
•H © Q
va C«-
cm in
u *
o
O O
r-l t-i
m
NO
!O•d© rH
43
Oj ©
U 43 |OHO
s a*
e -h o
d
^
•H «H
O
• ^ca
4> d id o o
U -H rH
-HCM
•HfiL
co
rH
o
•
© o
+» -H
Vl 43
d 0]
© *d*
§ io d
3 2
VA
.VA
O
VA
VA
VA
ca
VA
CM
VA
o
r
r^ va
o
*H O
o o
oo oo
CM VA
vO
rH rH
„va
VA
,JA
ca
VA
o
VA
vA
,JA
CA
^A
O
C^- VA
43
O ©
<S «H
> 8
5
go
u
©
a3
©
I
ft
d
OS0
a
M
3 S
©
2
o
Xi
43
©
i
rH «W
© O
©
© o
rH rH
d
©
h
o
ovo Nrw\
• • • • •
fA CAd" vp,\D
•r4 Q
9
M CA-d \A^OO O O O O
rH rH rH rH rH
X H H H X
IO
rH
^0
M O
h a
• ©
•H O
> rH
Vl
O
(A
o o
•H rH
+3
d
rH
t-Tvi
*
»h d
© o
4>
«H 43
d d
© "d*
o dW «h
o
Ih
I©
©
CV CM CAVO vO
ON H N CA VA
vA
^A\A^\A
VA-d rH
^va^va va
CA CM ©
•^A^A-VA
-d rH O
^A^A^A
CM O O
VA
>A
O
r>- o cavo cm
rH CM CM CAd"
©
O
-H
8 rH
O
rH U
it
U O
o o
{Z5 '
—
O rH CAO r-l
• • * • i
CM CA-d vavO
X X K H
O v«, CA CAVO
\g CM C^- CM CM
VP
vr
VA VA
VPid CM
-d cao
VA va VA
VA CM O
VA vA va
d* CM O
VA VA
CA O
VA
O
r>- o ca^o cm
rH CM CM CA^t
•g
i
o ©
o o
d mt
> a
03
B
© d-
o
d
o
© IO
rH rH
o
II
I
1 i
© Vt
09 O
<D
© ttf
m e
© ©
m -h
p +3
E 03
o
o
VA
-3" CV ^* O-CAN©
O O H
'o
rH
*i 'A
• L
t» o
OS • rH
•H B H
© W
I tH O
ON
2 d k>
4 Orl
U -H
•s^
r» -H Ol
«H O rH
CO •
o
I
o
© o
Vl +»
CD *^
" io a
w «H
!
ca-* mo o o
K K K
CA CA O VNVO rHOnOH CArH
Vf\ »a
\A*AVA
4 N O
>A
-3- O
.3- *A \a O
VA.JAJA
va va»A
O
CM C^- O CAM>H H H N N n
©
O
o
rH U
a} +»
p aU o
o o
525^
O 9
u o
ft
V©
• • •
CM CM (A
CM CM-3-
o o o
XXX
CACArH
-3" H
CM CAOO \T\00
• • • • •O O CM CM CA-3"
CA n»AO O O
HHH
o r»ov©M)\ariOHNH
NO
^A
,*A
CA
vt>^a^a
vA*A*A
\A CA O
\A,>A
rH O
,va vA
VT\ O
cm -3- r>- o cav© no n
rH rH rH CM CM (A rH CM CM
© fl
© OS
u
as
II
^A
^A
>A
VA VA VA
\A *A ©
VAVA
S
I!
Figure 1
The effect of time and speed of centrifugation on virus growth (early phase)
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Hours after inoculation of HJ virus
Supernate I: prepared "by centrifuging inoculum at 2000
rpm for 30 minutes.
Supernate II: prepared from Supernate I oy recentrifuging
at 3000 rpm for 45 minutes.
Sediment: resuspended sediment from Supernate II
inoculum.
The brain pools used to determine the points were centri-
fuged at the same speed - 2000 rpm for 30 minutes
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Figure 2
Growth curves of virus in the trains of mice inoculated with a 10~^ suspension
of HF virus
The effect of time and speed of centrifugation on virus growth*
The inocula and the Drain pools used to determine the
points were centrifuged at the speeds noted.
-j_ I ? 1 J .«_..»... I I-..-L 1
Pigure 3
Growth curves of virus in the brains of mice inoculated with three different
concentrations of EF virus
8-
2 i 6 8 10 Ik 16 22 26 30 3^ 38 io 44
Hours after inoculation of Hi1 virus
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Tigure 4
Growth curve of virus in mice immunized against vaccinia
10"1 inoculum (10^*3 MPLD per ml)
8-
3-
6 8 ' 12 l6~*
Hours after inoculation of EF virus
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Figure 5
Growth curve of virus in mice immunized against vaccinia 10 inoculum
(KP* 1 MPLD per ml)
Vaccinated mice received two intraabdominal
inject ions of vaccine lymph "before use

48.
Figure 6
Grovth curve of virus in mice immunized against vaccinia
10~5 inoculum MPLD per ml)
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